Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-flow nasal air versus caffeine for apnea of prematurity
NL-OMON20329Recruiting
- Sponsor
- MST & ZGT
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of caffeine in apnea of prematurity (AOP) (2 arms), sponsored by MST & ZGT. Primary endpoint: Primary outcome: treatment failure. Started Jun 2014; status: recruiting.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on NL-OMON20329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20329.